Table. Characteristics of neonates and carbapenemase-producing Klebsiella pneumoniae isolates from Korle-Bu Teaching Hospital, Ghana, 2017–2019*.
| Patient | Sample | Sex | MOD | DOS | Birthweight, kg | Cubicle | Shared space | Date of isolation | ST | Capsular serotype | Prior AB use | AB use after BSI | DOA, d | Vital status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KP007 | Carriage | F | CS | 13 | 1.4 | I | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP010 | Carriage | F | CS | 21 | 1.1 | II | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP011 | Carriage | M | SVD | 18 | 0.9 | I | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Dead |
| KP020 | Carriage | F | CS | 43 | 0.8 | II | No | 2017 Sep 21 | 48 | KL62 | AMK, CXC, MEM, CIP, VA | NA | NA | Alive |
| KP025 | Carriage | F | SVD | 15 | 1.2 | III | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP034 | Carriage | M | CS | 34 | 1.4 | III | Yes | 2017 Sep 21 | 17 | KL25 | AMK, CXC, CIP, MEM | NA | NA | Alive |
| KP035 | Carriage | F | CS | 30 | 1.4 | III | Yes | 2017 Sep 21 | 17 | KL25 | No | NA | NA | Alive |
| KP036 | Carriage | F | SVD | 36 | 1.3 | III | Yes | 2017 Sep 21 | 17 | KL25 | No | NA | NA | Alive |
| KP037 | Carriage | M | SVD | 12 | 2.1 | III | Yes | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP045 | Carriage | F | SVD | 11 | 1.7 | III | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | NA |
| KP047 | Carriage | F | SVD | 4 | 3.9 | III | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP052 | Carriage | M | CS | 12 | 3 | III | Yes | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP055 | Carriage | M | CS | 24 | 1.5 | III | Yes | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP056 | Carriage | M | SVD | 17 | 3.2 | III | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| K058 | Carriage | M | SVD | 33 | 1 | I | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| K221 | Carriage | F | SVD | 2 | 1.6 | III | No | 2017 Sep 21 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP233 | Carriage | M | SVD | 12 | 3.2 | III | No | 2018 Jan 19 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP242 | Carriage | M | SVD | 2 | 3.7 | III | No | 2018 Jan 19 | 17 | KL25 | AMK, CXC | NA | NA | Alive |
| KP0033 | Blood | M | SVD | 20 | 2.4 | I | NA | 2017 Oct 5 | 17 | KL25 | AMK, CXC, CAZ | MEM, CIP | 10 | Dead |
| KP0455 | Blood | M | SVD | 10 | 3.6 | II | NA | 2018 Jan 5 | 17 | KL25 | AMK, CXC | NA | 12 | Dead |
| KP0457 | Blood | F | SVD | 9 | 1.3 | II | NA | 2018 Jan 5 | 17 | KL25 | AMK, CXC | CIP | 69 | Alive |
| KP0879 | Blood | M | SVD | 13 | 4.4 | III | NA | 2018 Mar 19 | 17 | KL25 | MEM | MEM | NA | NA |
| KP2326 | Blood | F | A | 7 | 1.1 | I | NA | 2018 Dec 29 | 17 | KL25 | AMK, CXC | NA | 9 | Dead |
| KP2201 | Blood | M | CS | 10 | 1.3 | I | NA | 2018 Nov 24 | 17 | KL25 | AMK, CXC | MEM, CIP | 42 | Alive |
| KP2557 | Blood | M | SVD | 18 | 2.5 | I | NA | 2019 Feb 6 | 17 | KL25 | AMK, CXC | MEM | NA | Alive |
| KP2455 | Blood | F | CS | 10 | NA | III | NA | 2019 Jan 20 | 17 | KL25 | AMK, CXC | CIP | 27 | Alive |
| KP026 | Cot | II | 2017 Sep 21 | 17 | KL25 | |||||||||
| KP040 | Cot | III | 2017 Sep 21 | 17 | KL25 | |||||||||
| KP090 | Trolley handle | III | 2017 Sep 21 | 17 | KL25 |
*Blank spaces indicate not applicable. AB, antimicrobial drug; AMK, amikacin; BSI, bloodstream infections; CAZ, ceftazidime; CIP, ciprofloxacin; CS, cesarean section; CXC, cloxacillin; DOA, duration of admission; DOS, duration of stay before specimen collection; MOD, mode of delivery; MEM, meropenem; NA, not available; ST, multilocus sequence type.